The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase II, open-label, multicenter study of the ALK inhibitor alectinib in an ALK+ non-small-cell lung cancer (NSCLC) U.S./Canadian population who had progressed on crizotinib (NP28761).
 
Leena Gandhi
Honoraria - Merck
Consulting or Advisory Role - Genentech/Roche; Merck
Travel, Accommodations, Expenses - Genentech/Roche; Merck
 
Alice Shaw
Honoraria - Novartis; Pfizer; Roche Pharma AG
Consulting or Advisory Role - Genentech; Ignyta; Novartis; Pfizer; Roche Pharma AG
Research Funding - ARIAD (Inst); Genentech (Inst); Novartis (Inst); Pfizer (Inst)
 
Shirish M. Gadgeel
Consulting or Advisory Role - Roche/Genentech
Speakers' Bureau - Genentech
 
Gregory Riely
Honoraria - Celgene
Consulting or Advisory Role - ARIAD; Mersana; Novartis; Roche Pharma AG
Research Funding - GlaxoSmithKline (Inst); Infinity Pharmaceuticals (Inst); Millennium (Inst); Novartis (Inst); Pfizer (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Novartis
 
Jeremy Cetnar
No Relationships to Disclose
 
Howard Jack West
Honoraria - Celgene; Foundation Medicine; Genentech/Roche; Merck; Novartis; Pfizer
Consulting or Advisory Role - Celgene; Foundation Medicine; Genentech/Roche; Merck; Novartis; Pfizer
Travel, Accommodations, Expenses - Celgene; Foundation Medicine; Genentech/Roche; Merck; Novartis; Novartis
 
D. Ross Camidge
Honoraria - Genentech/Roche
Consulting or Advisory Role - Genentech/Roche
 
Mark A. Socinski
Honoraria - Genentech
Consulting or Advisory Role - Genentech
Speakers' Bureau - Genentech
Research Funding - Genentech (Inst)
 
Alberto Chiappori
Consulting or Advisory Role - Genentech; GlaxoSmithKline; Novartis; Pfizer
Speakers' Bureau - Boehringer Ingelheim; Celgene; Genentech; Novartis; Pfizer
 
Tarek Mekhail
Honoraria - Celgene; Genentech; Lilly
Consulting or Advisory Role - Celgene; Genentech; Pfizer
Speakers' Bureau - Celgene; Genentech; Lilly; Novartis
Research Funding - Bristol-Myers Squibb (Inst); Celgene (Inst); Genentech (Inst); Lilly (Inst)
 
Bo H. Chao
Consulting or Advisory Role - Boehringer Ingelheim
Research Funding - ARIAD (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Clovis Oncology (Inst); Genentech (Inst); GlaxoSmithKline (Inst); Novartis (Inst); Roche Pharma AG (Inst)
 
Hossein Borghaei
Consulting or Advisory Role - Bristol-Myers Squibb (Inst); Celgene (Inst); Genentech (Inst); Lilly (Inst)
Research Funding - Millennium (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Celgene; Genentech; Lilly
 
Kathryn A. Gold
Honoraria - Bristol-Myers Squibb
Consulting or Advisory Role - Pfizer
Research Funding - ARIAD (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Puma Biotechnology (Inst); Roche/Genentech (Inst)
 
Ali Hassan Zeaiter
Employment - Proacta
Leadership - Proacta
Stock and Other Ownership Interests - Proacta
 
Walter Bordogna
Employment - Proacta
 
Bogdana Balas
Employment - Proacta; Proacta (I)
Stock and Other Ownership Interests - Proacta
 
Oscar Puig
Employment - Roche Pharma AG
Stock and Other Ownership Interests - Roche Pharma AG
Patents, Royalties, Other Intellectual Property - Roche
 
Volkmar Henschel
Employment - Proacta
Stock and Other Ownership Interests - Proacta
 
Sai-Hong Ignatius Ou
Honoraria - Pfizer
Consulting or Advisory Role - Pfizer; Roche Pharma AG
Speakers' Bureau - Boehringer Ingelheim; Roche Pharma AG
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Clovis Oncology (Inst); Pfizer (Inst); Roche Pharma AG (Inst)